Menu
GWAS Study

Eighty-eight variants highlight the role of T cell regulation and airway remodeling in asthma pathogenesis.

Olafsdottir TA, Theodors F, Bjarnadottir K et al.

31959851 PubMed ID
GWAS Study Type
787635 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

OT
Olafsdottir TA
TF
Theodors F
BK
Bjarnadottir K
BU
Bjornsdottir US
AA
Agustsdottir AB
SO
Stefansson OA
IE
Ivarsdottir EV
SJ
Sigurdsson JK
BS
Benonisdottir S
EG
Eyjolfsson GI
GD
Gislason D
GT
Gislason T
GS
Guðmundsdóttir S
GA
Gylfason A
HB
Halldorsson BV
HG
Halldorsson GH
JT
Juliusdottir T
KA
Kristinsdottir AM
LD
Ludviksdottir D
LB
Ludviksson BR
MG
Masson G
NK
Norland K
OP
Onundarson PT
OI
Olafsson I
SO
Sigurdardottir O
SL
Stefansdottir L
SG
Sveinbjornsson G
TV
Tragante V
GD
Gudbjartsson DF
TG
Thorleifsson G
SP
Sulem P
TU
Thorsteinsdottir U
NG
Norddahl GL
JI
Jonsdottir I
SK
Stefansson K
Chapter II

Abstract

Summary of the research findings

Asthma is one of the most common chronic diseases affecting both children and adults. We report a genome-wide association meta-analysis of 69,189 cases and 702,199 controls from Iceland and UK biobank. We find 88 asthma risk variants at 56 loci, 19 previously unreported, and evaluate their effect on other asthma and allergic phenotypes. Of special interest are two low frequency variants associated with protection against asthma; a missense variant in TNFRSF8 and 3' UTR variant in TGFBR1. Functional studies show that the TNFRSF8 variant reduces TNFRSF8 expression both on cell surface and in soluble form, acting as loss of function. eQTL analysis suggests that the TGFBR1 variant acts through gain of function and together with an intronic variant in a downstream gene, SMAD3, points to defective TGFβR1 signaling as one of the biological perturbations increasing asthma risk. Our results increase the number of asthma variants and implicate genes with known role in T cell regulation, inflammation and airway remodeling in asthma pathogenesis.

16,247 European ancestry cases, 346,486 European ancestry controls, 52,942 cases, 355,713 controls

Chapter III

Study Statistics

Key metrics and study information

787635
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.K., Iceland
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.